Free Content Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine1A receptor-mediated feedback: a microdialysis study in the amygdala

Authors: Bosker, F. J.1; Cremers, T. I. F. H.2; Jongsma, M. E.2; Westerink, B. H. C.2; Wikström, H. V.2; den Boer, J. A.1

Source: Journal of Neurochemistry, Volume 76, Number 6, March 2001 , pp. 1645-1653(9)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Microdialysis was used to assess the involvement of postsynaptic 5-hydroxytryptamine1A (5-HT1A) receptors in the regulation of extracellular 5-HT in the amygdala. Local infusion of the 5-HT1A receptor agonist flesinoxan (0.3, 1, 3 µm) for 30 min into the amygdala maximally decreased 5-HT to 50% of basal level. Systemic administration of citalopram (10 µmol/kg) increased 5-HT to 175% of basal level. Local infusion of 1 µmof the 5-HT1A receptor antagonist WAY 100.635 into the amygdala augmented the effect of citalopram to more than 500% of basal 5-HT level. 5-HT1A receptor responsiveness after chronic citalopram treatment was determined in two ways. First, by local infusion of 1 µmflesinoxan for 30 min into the amygdala, which showed a significant 63% reduction in response (area under the concentration-time curve; AUC) for the citalopram group compared to the saline group. Second, by systemic administration of citalopram (10 µmol/kg), which increased 5-HT to 350% of basal level. The effect was larger than in untreated animals, but more important, local infusion of 1 µmWAY 100.635 into the amygdala now failed to augment the effect of citalopram. Both the flesinoxan and WAY 100.635 data suggest an involvement of postsynaptic 5-HT1A receptor-mediated feedback in the amygdala, which diminishes following chronic citalopram treatment.

Keywords: amygdala; augmentation; citalopram; desensitization; feedback; 5-HT1A receptor

Document Type: Research article

DOI: 10.1046/j.1471-4159.2001.00194.x

Affiliations: 1: Department of Psychiatry, Academic Hospital Groningen, the Netherlands 2: Department of Medicinal Chemistry, University Center for Pharmacy, University of Groningen, the Netherlands

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A